期刊文献+

宫颈癌介入化疗前后组织中NF-κB、MMP-9的表达及意义 被引量:1

Expression and significance of NF-κB and MMP-9 in cervical carcinoma tissues before and after interventional chemotherapy
下载PDF
导出
摘要 目的观察宫颈癌介入化疗前后组织中核转录因子-κB(nuclear factor kappa-B,NF-κB)和MMP-9(matrix metalloproteinase,MMP-9)的表达及临床意义。方法采用免疫组织化学SP法检测80例宫颈癌(CSES)行动脉介入化疗前后、70例子宫颈上皮内瘤样变(CIN)及50例正常子宫颈组织(NCE)NF-κB和MMP-9的表达,分析其与临床病理特征的关系,探讨二者在介入化疗前后的表达情况及与介入化疗效果的关系。结果在CSES、CIN及NCE中,NF-κB、MMP-9蛋白阳性表达率分别为72.5%、18.6%、0%和68.8%、15.7%、0%,差异具有统计学意义(P<0.05)。NF-κB、MMP-9表达与宫颈癌不同的病理分级、临床分期和淋巴结转移状况有关(P<0.05),与患者年龄和组织学类型无关,且二者表达呈明显正相关(r=0.872,P<0.05)。介入化疗总有效率为81.3%,且与治疗前比较NF-κB、MMP-9蛋白表达均显著降低。结论宫颈癌患者存在NF-κB和MMP-9的过表达,介入化疗后二者表达显著降低。介入化疗可通过抑制肿瘤细胞增殖、浸润和转移发挥治疗宫颈癌的作用。 Objective To investigate the expression and significance of NF-κB and MMP-9 in cervical carcinoma tissues before and after interventional chemotherapy ( IC).Methods The expression levels of NF-κB and MMP-9 were detected by immunohistochemistry method in 80 cases of cervical carcinoma ( CSES) before and after IC,70 cases of cervical intraepithelial neoplasm (CIN) and 50 cases of normal cervical tissues (NCE).The therapeutic effect of IC and the correlation between the expressions and clinical pathological characteristics before and after IC were observed and analyzed .Results Among CSES,CIN and NCE tissues,the positive expression rates of NF-κB and MMP-9 proteins were 72.5%,18.6%,0 and 68.8%,15.7%,0,respectively.The expression levels of NF-κB and MMP-9 in CSES were significantly higher than those in CIN and NCE ( P 〈0.05).The expression levels of NF-κB and MMP-9 were correlated to the degree of cell differentiation ,clinical stage and lymph node metastasis of cervical carcinoma ,however,which were not related with patient 's age and histological type.The expression levels of NF-κB were positively correlated with those of MMP-9 ( r =0.872, P 〈0.05).The total effective rate of IC was 81.3%,moreover,the expression levels of NF-κB and MMP-9 after IC were significantly decreased ,as compared with those before IC .Conclusion The overexpression of NF-κB and MMP-9 exists in patients with cervical carcinoma and IC can significantly reduce the expression levels of NF-κB and MMP-9,as a result,which may inhibit the proliferation ,infiltration,invasion and metastasis of tumor cells .
出处 《河北医药》 CAS 2013年第22期3372-3374,共3页 Hebei Medical Journal
关键词 宫颈肿瘤 NF—κB MMP-9 介入化疗 cervical carcinoma NF-κB MMP-9 interventional chemotherapy
  • 相关文献

参考文献8

  • 1杨斌,肖梅,陈赛英,张佃乾.宫颈癌介入化疗前后组织中的CyclinD1、Ki-67的变化及意义[J].现代肿瘤医学,2009,17(4):713-715. 被引量:12
  • 2中华医学会妇产科分会中华妇产科杂志编辑委员会.妇科常见肿瘤诊断与治疗规范(草案)[J].中华妇产科杂志,1998,(33):694.
  • 3Du CX,Wang Y. Expression of P-Akt,NF-kappa B and their correlationwith human papillomavirus infection in cervical carcinoma. Eur J Gynae-col Oncol,2012,33:274-277.
  • 4Li J,Jia H,Xie L,et al. Association of constitutive nuclear factor-kappaBactivation with aggressive aspects and poor prognosis in cervical cancer.Int J Gynecol Cancer,2009,19 :1421-1426.
  • 5Roomi MW, Monterrey JC, Kalinovsky T, et al. In vitro modulation ofMMP-2 and MMP-9 in human cervical and ovarian cancer cell lines bycytokines,inducers and inhibitors. Oncol Rep,2010,23 :605-614.
  • 6Yoonseo K. Celastrol inhibits breast cancer cell invasion via suppressionof NF-KB-mediated matrix metalloproteinase-9 expression. Cell PhysiolBiocKem,2011,28 :175-184.
  • 7杜晓晋,吴素慧,尚海霞.NF-κB、MMP-9在宫颈癌细胞中的表达及意义[J].当代医学,2012,18(16):6-7. 被引量:2
  • 8杨秀凤,魏晓强,张文华.宫颈癌介入化疗前后MMP-2和Ki67表达及意义[J].齐鲁医学杂志,2010,25(5):391-393. 被引量:9

二级参考文献18

  • 1罗仪,陈双郧,刘永珍,宋鑫,张昌军.Survivin、CD_(44v6)、MMP-2在宫颈癌组织中的表达与侵袭、转移的关系[J].实用妇产科杂志,2006,22(1):30-33. 被引量:12
  • 2李东辉,李明众,张薛榜.β-catenin和Ki-67在人宫颈癌组织中的表达及其意义[J].实用癌症杂志,2007,22(1):28-30. 被引量:6
  • 3Sardi JE, Boixadera MA, Sardi JJ. Neoadjuvant chemotherapy in cervical cancer: a new trend [ J ]. Curr Opin Obstet Gynecol, 2005,17( 1 ) :43 -47.
  • 4Freemantle SJ, Liu X, Feng Q, et al. Cyclin degradation for cancer therapy and chemoprevention [ J ]. Cell Biochem, 2007,102 ( 4 ) : 869 - 877.
  • 5Slama J, Cibula D, Freitag P, et al. Contribution of neoadjuvant chemotherapy for operability of cancers of the uterine cervix [ J ]. Ceska Gynekol,2007,72(2) :116 - 119.
  • 6Arooz T, Yam CH, Siu WY, et al. On the concentrations of cyclins and cyclin- dependent kinases in extracts of cuhured human cells [J]. Biochemistry,2000,39 (31) :9494 -9501.
  • 7Lukas Bartkova J, Bartek J. Convergence of mitogenic signaling cascades from diverse classes of receptors at the cyclinD - cyclin - dependent kinase - pRb - controlled G1 checkpoint [ J]. Mol Cell Biol, 1996,16 (12) :6917 - 6925.
  • 8Ferrandina G, Ranelletti FO, Larocca LM, et al. Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer[ J ]. Clin Cancer Res,2001,7 (9) :2656 - 2661.
  • 9YAMAKAWA Y,FUJIMURA M,HIDAKA T,et al.Neoadjuvant intraarterial infusion chemotherapy in patients with stage Ⅰb2-Ⅲb cervical cancer[J].Gynecol Oncol,2000,77(2):264-270.
  • 10Aggarwal BB.Nuclear factor-kappa B:the enemy with in [J].Oancer Cell, 2004,6(5): 203--208.

共引文献22

同被引文献16

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部